The global BPH treatment market is expected to grow from USD 33,031.10 million in 2024 to USD 47,045.80 million by 2034, at a ...

The FDA has approved Gemtesa® for men with overactive bladder symptoms receiving pharmacological therapy for BPH.

We are excited to reach this important milestone in the Expander-2 Pivotal Trial,” said Paul Edwards, President and CEO of Prodeon Medical. “Completing enrollment is a key step in our mission to ...

Annual check-ups save lives by detecting prostate issues early, yet many men avoid these crucial tests due to fear or misconceptions. Prostate health ...

As temperatures drop, a trend of increased prostate-related problems among men over 60 has been observed by experts. Benign prostatic hyperplasia (BPH), also called prostate gland enlargement, is a ...

In adult men, the most common cause by far is prostate enlargement ... The urologist will discuss your options, including ...

While a stuffy nose is a common side effect of oral ED medications, switching from Cialis to shorter-lasting options like ...

To evaluate the accuracy, comprehensiveness, empathetic tone, and patient preference for AI and urologist responses to patient messages concerning common BPH questions across phases of care.

MORGANTOWN – Mon Health Medical Center is once again on the leading edge of surgery – this time with a new technology to treat enlarged prostate ... provide advanced treatment options to ...

Fazakerley grandad Bernie Duggan, 79, who was diagnosed with an enlarged prostate in October last ... waiting times for patients needing this treatment, improve quality of clinical service and ...

The most common adverse reactions with treatment were headache ... men with unresolved symptoms of OAB while being treated for BPH, which underscores our urgency to deliver for those affected ...